The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.
Anne S. Tsao, MD
Consulting fees/advisory boards: AstraZeneca, Boehringer-Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb, Eli Lilly and Company, EMD Serono, Inc., F. Hoffman-La Roche Ltd., Genentech, Huron, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Seattle Genetics, Takeda Pharmaceuticals North America, Inc.
Contracted research: Boehringer-Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb, Eli Lilly and Company, Epizyme, Genentech, Merck & Co., Inc., Millennium: The Takeda Oncology Company, Polaris Pharmaceuticals, Seattle Genetics
The peer reviewers and activity planners have no financial relationships to disclose.